
1. Technology overview
b-rayZ AG is a Swiss company with headquarters at Wagistrasse 21 in Schlieren, Switzerland, and a US entity in New Jersey. It develops AI solutions for breast imaging aimed at technologists, radiologists, clinical managers and IT staff.
The b-rayZ suite is a modular platform for digital mammography and tomosynthesis. Modules include b-quality for real-time image quality feedback, b-density for ACR density classification, b-diagnostics for lesion detection and BI-RADS-compliant reports, b-smart for a performance dashboard and b-risk for a risk score (coming soon). It integrates with compatible mammography systems and existing PACS through DICOM and is CE-marked under the EU MDR.
2. Highlighted features & specifications
- b-quality: real-time image quality feedback for technologists to reduce recalls.
- b-density: ACR breast density classification aligned with the BI-RADS 5th edition.
- b-diagnostics: lesion and calcification analysis with BI-RADS-compliant report recommendations.
- b-smart: dashboard for image quality by technologist, facility and time span.
- PACS integration: connects through a b-box to local PACS and uses DICOM mammograms.
- b-risk: breast cancer risk score, listed as coming soon.
3. Potential application
Breast imaging centres in Vietnamese hospitals could use b-quality to standardize technologist positioning. Screening programs could use b-density to flag women for supplementary ultrasound. Private imaging chains could use b-smart to compare quality across sites.
4. Benefits
Real-time quality feedback helps avoid positioning errors; the vendor reports a 60 percent reduction in inadequate images with short-term use. Density classification reports 90 percent accuracy versus consenting physicians (vendor figure). Initial integration takes about 30 minutes. Audit-ready documentation supports compliance.
5. Market trends & opportunities
Breast screening programs generate large mammography volumes while radiologists are scarce, which drives AI for quality control, density and triage. Vietnam is expanding cancer screening in major hospitals, and AI that works with existing PACS could support this, subject to local regulatory clearance.
6. Other information
b-rayZ AG, Wagistrasse 21, 8952 Schlieren, Switzerland; US office b-rayZ LLC in Fort Lee, New Jersey. Affidea Group selected b-rayZ as preferred breast imaging AI partner in June 2025. Partnership with SC PACS Bulgaria in July 2025. Holds CE mark under EU MDR and a DQS Med certificate.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































